Literature DB >> 31362140

3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes.

Hamisha Ardalani1, Srikumar Sengupta2, Victoria Harms3, Vernella Vickerman2, James A Thomson4, William L Murphy5.   

Abstract

Human-induced pluripotent stem cell (hiPSC)-derived hepatocytes (iHEP) offer an attractive alternative to primary human hepatocytes (PHH) for drug toxicity studies, as PHHs are limited in supply, vary in their metabolic activity between donors, and rapidly lose their functionality in vitro. However, one of the major drawbacks with iHEP cells in drug safety studies is their decreased phenotypic maturity, with lower liver specific enzyme activity compared with that of PHH. Here we evaluated the effects of 3D culture and non-parenchymal cells on the maturation of iHEPs. We describe a serum-free, chemically defined 3D in vitro model using iHEP cells, which is compatible with automation and conventional assay plates. The iHEP cells cultured in this model form polarized aggregates with functional bile canaliculi and strongly increased expression of albumin, urea and genes encoding phase I and II drug metabolism enzymes and bile transporters. Cytochrome P450-mediated metabolism is significantly higher in 3D iHEP aggregates compared to 2D iHEP culture. Furthermore, addition of human liver sinusoidal endothelial cells (sECs) and iPS-derived endothelial cells (iECs) improved mature hepatocyte function and CYP450 enzyme activity. Also, ECs formed endothelial networks within the hepatic 3D cultures, mimicking aspects of an in vivo architecture. Collectively, these results suggest that the iHEP/EC aggregates described here may have the potential to be used for many applications, including as an in vitro model to study liver diseases associated with sinusoidal endothelial cells. STATEMENT OF SIGNIFICANCE: iPS-derived hepatocytes provide an inexhaustible source of cells for drug screening, toxicology studies and cell-based therapies, but lack mature phenotype of adult primary human hepatocytes (PHH). Herein, we show that 3D culture of iPS-derived hepatocytes and their co-culture with human sinusoidal endothelial cells (sECs) to improve their maturity.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D culture; Hepatocyte function; Human induced pluripotent stem cell (hiPSC)-derived hepatocytes

Year:  2019        PMID: 31362140     DOI: 10.1016/j.actbio.2019.07.047

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  14 in total

Review 1.  The application of three-dimensional cell culture in clinical medicine.

Authors:  Qiao Chen; Youbin Wang
Journal:  Biotechnol Lett       Date:  2020-09-15       Impact factor: 2.461

Review 2.  Using liver models generated from human-induced pluripotent stem cells (iPSCs) for evaluating chemical-induced modifications and disease across liver developmental stages.

Authors:  Celeste K Carberry; Stephen S Ferguson; Adriana S Beltran; Rebecca C Fry; Julia E Rager
Journal:  Toxicol In Vitro       Date:  2022-06-07       Impact factor: 3.685

3.  Synthetic alternatives to Matrigel.

Authors:  Elizabeth A Aisenbrey; William L Murphy
Journal:  Nat Rev Mater       Date:  2020-05-27       Impact factor: 66.308

Review 4.  Human liver model systems in a dish.

Authors:  Wendy L Thompson; Takanori Takebe
Journal:  Dev Growth Differ       Date:  2021-02-02       Impact factor: 2.053

5.  Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.

Authors:  Felipe T Lee-Montiel; Alexander Laemmle; Verena Charwat; Laure Dumont; Caleb S Lee; Nathaniel Huebsch; Hideaki Okochi; Matthew J Hancock; Brian Siemons; Steven C Boggess; Ishan Goswami; Evan W Miller; Holger Willenbring; Kevin E Healy
Journal:  Front Pharmacol       Date:  2021-05-07       Impact factor: 5.810

6.  Real-time fluorometric evaluation of hepatoblast proliferation in vivo and in vitro using the expression of CYP3A7 coding for human fetus-specific P450.

Authors:  Shota Okuyama; Fumihiko Kawamura; Musashi Kubiura; Saori Tsuji; Mitsuhiko Osaki; Hiroyuki Kugoh; Mitsuo Oshimura; Yasuhiro Kazuki; Masako Tada
Journal:  Pharmacol Res Perspect       Date:  2020-10

Review 7.  Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing.

Authors:  Meixian Jin; Xiao Yi; Wei Liao; Qi Chen; Wanren Yang; Yang Li; Shao Li; Yi Gao; Qing Peng; Shuqin Zhou
Journal:  Stem Cell Res Ther       Date:  2021-01-25       Impact factor: 6.832

8.  Robust expansion and functional maturation of human hepatoblasts by chemical strategy.

Authors:  Tingcai Pan; Jiawang Tao; Yan Chen; Jiaye Zhang; Anteneh Getachew; Yuanqi Zhuang; Ning Wang; Yingying Xu; Shenglin Tan; Ji Fang; Fan Yang; Xianhua Lin; Kai You; Yi Gao; Yin-Xiong Li
Journal:  Stem Cell Res Ther       Date:  2021-02-25       Impact factor: 6.832

Review 9.  Organogenesis in vitro.

Authors:  Kentaro Iwasawa; Takanori Takebe
Journal:  Curr Opin Cell Biol       Date:  2021-08-02       Impact factor: 8.382

10.  Co-culture with mouse embryonic fibroblasts improves maintenance of metabolic function of human small hepatocyte progenitor cells.

Authors:  Srikumar Sengupta; Brian Johnson; Morten Seirup; Hamisha Ardalani; Bret Duffin; Gregory A Barrett-Wilt; Ron Stewart; James A Thomson
Journal:  Curr Res Toxicol       Date:  2020-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.